Tag: ESOC

Jesse Dawson NeuroNews

Jesse Dawson

“It is an amazing time to work in stroke medicine,” Jesse Dawson tells NeuroNews. Looking back at his career, he discusses the field’s biggest...
resilient trial results

Thrombectomy proved efficacious in Latin America as the final results of...

After receiving a standing ovation when presented at the European Stroke Organisation Conference (ESOC; 22–24 May, Milan, Italy) last year, the final results of...
BASICS study basilar artery occlusion

Endovascular therapy fails to outperform best medical management in basilar artery...

Final results of the Basilar artery international cooperation study (BASICS) have been reported by Wouter J Schonewille (University Medical Centre Utrecht, Utrecht, the Netherlands)...

Antiplatelet therapy shows “reassuring effects” on the risk of recurrent intracerebral...

“Starting antiplatelet therapy after intracerebral haemorrhage associated with antithrombotic drug use demonstrated reassuring effects on the risk of recurrent haemorrhage,” said Rustam Al-Shahi Salman...
Alteplase

Alteplase at 0.6mg/kg for stroke with unknown time of onset is...

Although an acceptable safety profile was demonstrated for MRI-guided thrombolysis with alteplase at 0.6mg/kg for stroke with unknown time of onset, the latter approach...

Combining contact aspiration with stent retriever techniques elicits no superiority

The first randomised controlled trial (RCT) to directly compare the efficacy of the combined use of contact aspiration and stent retriever against a stent...
RESILIENT trial

The “overwhelming” efficacy of mechanical thrombectomy pursues in developing countries: RESILIENT,...

The final results of the first thrombectomy trial in a developing country convey the “overwhelming efficacy of mechanical thrombectomy”. Given that 35% of the...